Herpesvirus
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons (NCT05683834) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-09-22 |
Track Herpesvirus automatically
Every clearance here is in the API, with alerts when new ones post.